Oorsprong van het eerstegraads netwerk van Susanna Urdmark
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Rhenman & Partners Asset Management AB
 Rhenman & Partners Asset Management AB Investment ManagersFinance Rhenman & Partners Asset Management AB (Rhenman & Partners) is an independent Swedish alternative investment management firm which was founded in 2008 by a group of senior asset management industry executives including Henrik Rhenman and Göran Nordström. Headquartered in Stockholm, the firm is exclusively focused on the healthcare sector and manages the Rhenman Healthcare Equity L/S Fund, supported by a Scientific Advisory Board with a network of scientists and experts at renowned scientific institutions, including the Karolinska Institute and the University of Uppsala.
6
| Private Company | Investment Managers | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Susanna Urdmark via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Karolinska Institutet | College/University | Doctorate Degree | |
| Humboldt State University | College/University | Graduate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree | |
| University of Stockholm | College/University | Graduate Degree Undergraduate Degree | |
GlaxoSmithkline AB
 GlaxoSmithkline AB Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AB is a company that manufactures pharmaceutical products. GlaxoSmithKline AB is based in Solna, Sweden. Founded in 1983. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Swedsec Licensiering AB
 Swedsec Licensiering AB Miscellaneous Commercial ServicesCommercial Services Swedsec Licensiering AB is a Swedish company that focuses on strengthening competence and customer protection in the financial industry. The private company's licensing has been a cornerstone of this effort since its inception. Agneta Oscarsson has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Novartis Pharma (Sweeden) | Corporate Officer/Principal |
Statistieken
Internationaal
| Zweden | 8 |
| Verenigde Staten | 2 |
Sectoraal
| Consumer Services | 5 |
| Health Technology | 2 |
| Finance | 2 |
| Commercial Services | 2 |
Operationeel
| Chief Executive Officer | 3 |
| Analyst-Equity | 3 |
| Graduate Degree | 3 |
| Portfolio Manager-Equities | 2 |
| Undergraduate Degree | 2 |
Sterkste connecties
| Insiders | |
|---|---|
| Teresa Isele | 5 |
| Amennai Beyeen | 4 |
| Hugo Schmidt | 2 |
| Kaspar Hållsten | 2 |
| Göran Nordström | 1 |
| Pontus Liljeblad | 1 |
- Beurs
- Insiders
- Susanna Urdmark
- Bedrijfsconnecties
